By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Intercept Pharmaceuticals 

450 W 15th Street
Suite 505
New York City  New York  10011  U.S.A.
Phone: 646-747-1000 Fax: 646-747-1001


SEARCH JOBS


Industry
Pharmaceutical






Company News
Intercept Pharma (ICPT) Files New Drug Submission To Health Canada For Marketing Approval Of Obeticholic Acid For The Treatment Of Patients With Primary Biliary Cholangitis 9/19/2016 8:54:36 AM
Intercept Pharma (ICPT) To Present At Upcoming Investor Conferences 9/2/2016 7:46:10 AM
Intercept Pharma (ICPT) Release: The New England Journal of Medicine Publishes Results Of Phase III POISE Trial Of Ocaliva (Obeticholic Acid) For The Treatment Of PBC 8/18/2016 8:13:09 AM
Intercept Pharma (ICPT) To Report Second Quarter 2016 Financial Results On August 4 And Present At Upcoming Conference 7/28/2016 10:19:58 AM
5 Biotech Stocks on the Brink of Breaking Out 7/25/2016 6:08:30 AM
Almac Group's Rapid Launch Services Support U.S. Approval Of Intercept Pharma (ICPT)'s First Commercial Orphan Drug Product 7/21/2016 9:17:18 AM
Almac Group's Rapid Launch Services Support U.S. Approval Of Intercept Pharma (ICPT)'s First Commercial Orphan Drug Product 7/14/2016 9:28:35 AM
Intercept Pharma (ICPT) Taps Former Novartis AG (NVS) Exec to Replace Longtime CFO 6/10/2016 5:42:45 AM
Why Intercept Pharma (ICPT) Just Became an Even More Attractive Takeover Target 5/31/2016 6:51:37 AM
Intercept Pharma (ICPT)'s Liver Drug Wins Accelerated Approval by the FDA 5/31/2016 6:11:12 AM
12345678910...
//-->